We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Family Medicine & Nutrition

Does Drinking More Than 3.5 Cups of Milk Weekly Raise Liver Cancer Risk? Unpacking the Facts Behind the Rumor

MedXY Editorial Team•Oct 8, 2025•Family Medicine & Nutrition
epidemiologymilknutrition guidelines

Introduction: Understanding the Context

Milk is a staple in many diets worldwide, celebrated for its rich nutrients including high-quality protein and calcium essential for bone health. However, recent headlines reporting a Harvard study suggesting that drinking more than 3.5 cups of milk per week may increase the risk of liver cancer by 45% have caused alarm and confusion among the public. This has led many regular milk consumers to question the safety of their dietary habits.

Is milk truly a cancer risk? Or is this another case of statistics getting misinterpreted in public discourse? This article aims to clarify the scientific findings, address misconceptions, and provide practical advice on milk consumption grounded in evidence.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unraveling Assortative Mating: How Parental Similarity Shapes Psychiatric Disorder Heritability and Prevalence at the Population LevelA large Danish cohort study reveals that partner similarity for psychiatric disorders significantly inflates both prevalence and heritability estimates, highlighting important public health and genetic counseling implications.Sep 27, 2026Rising Prevalence of Non-Cystic Fibrosis Bronchiectasis in US Primary Care: Insights from a Decade of Electronic Health RecordsBetween 2015 and 2025, non-cystic fibrosis bronchiectasis prevalence in the US primary care population increased by 133%, predominantly affecting older, white, female patients with Medicare coverage.Sep 25, 2026Early and Elevated Systemic Physical Multimorbidity in Schizophrenia-Spectrum and Bipolar Disorders: Insights from a Queensland Hospital Cohort StudyThis statewide cohort study reveals significantly higher incidence and earlier onset of systemic physical multimorbidity among people with schizophrenia-spectrum or bipolar disorders compared to matched controls, highlighting urgent needs fSep 24, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Rising Burden of Non-Cystic Fibrosis Bronchiectasis in U.S. Primary Care: A Decade of Prevalence Trends and Demographic Insights (2015–2025)
A large-scale EHR study reveals a 133% increase in non-cystic fibrosis bronchiectasis prevalence in U.S. adults from 2015 to 2025, with marked demographic disparities.
Sep 24, 2026
Global Burden of Disorders of Gut-Brain Interaction: Insights from Rome V Versus Rome IV CriteriaThe Rome V global epidemiology survey confirms a high prevalence of disorders of gut-brain interaction (DGBI) worldwide, consistent with prior Rome IV findings, underscoring a significant and persistent global clinical burden.Sep 15, 2026
Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant PhenotypesThe PORTHOS study reveals a 16.5% prevalence of heart failure among Portuguese adults aged 50+, with HFpEF constituting over 90% of cases, mostly undiagnosed, highlighting the need for enhanced screening strategies in aging populations.Sep 15, 2026